Autopsy report · NCT00107081
Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting
Cause of deathSlow enrollment
“Accrual goal for interventional part not achievable”
Life of this trial
- Registered 1 year 3 months after it had already started.
- Ran for about 3 years 11 months before it stopped.
- 70 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Swiss Pediatric Oncology Group
- Sponsor type
- University, hospital or other
- Conditions
- Fever; Neutropenia; Cancer
- Interventions
- ciprofloxacin and amoxicillin; Outpatient management; i.v. antibiotics; inpatient management
- Participants
- 70
- Sites
- 12
- Countries
- Germany, Netherlands, Switzerland
Trials that died the same way
- Trial of Daily Pulse Interleukin-2 With Famotidine in Acute Myelogenous Leukemia
“Unable to meet accrual goals” - Improving Treatment for Children With Intellectual and Developmental Disabilities and Problem Behavior in Schools
“Insufficient resources to implement intervention” - Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory
“Accrual goal Met” - Stellate Ganglion Block in Head and Neck Cancer Surgery
“Slow accrual, lack of benefit between intervention and control arms on interim analysis” - A Study of Contrast-Enhanced Mammography (CEM) Scans in People With Breast Cancer
“Challenges to participant accrual”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.